The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
Oxford, UK: CREDOS announces the launch of ‘Biotherapeutics News and Views’. Published quarterly, this newsletter will aim to cover key topics in the biopharmaceutical industry. CREDOS is a specialist consultancy tailored to the discovery and development of biological therapeutics (www.credos-bio.co.uk)
Please click here to open the newsletter
CREDOS is a leading source of specialist technical expertise & consulting services for antibody and protein-based therapeutic discovery & development. Founded in 2015, CREDOS consultants share an established track record in biotherapeutic drug discovery, collectively spanning all disciplines from project set-up, translational studies through to regulatory filing. CREDOS supports a wide range of clients providing services which include the formulation and execution of very early discovery, as well as later development plans for various biotherapeutic modalities; the creation of virtual multi-disciplinary teams for complex projects; due diligence opportunities and risk assessments; life cycle management of biologics portfolios; and bespoke training to address gaps in knowledge.
To find out more please contact Emma Campbell, Director, CREDOS, on 07765 220458 or email email@example.com, or visit our website www.credos-bio.co.uk
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, firstname.lastname@example.org, and we will post.